Answers are grounded in this paper and cite their sources.
Genetic influence on medication response has been well documented; yet, the clinical integration of pharmacogenetics has been slow.Lack of knowledge on the fundamentals of pharmacogenetic testing among clinicians and the complexities surrounding test selection, results interpretation, and clinical utility, among others, contribute to this slow adoption.In this paper, we describe integration of pharmacogenetics in the clinic, selection of target population and testing laboratories, team of expertise needed, available resources, and critical considerations for accurate interpretation of test results.We also discuss phenoconversion and pharmacogenetic utility in special populations including pediatrics, pregnant women and transplant patients.Ultimately, it should be observed that pharmacogenetics is an additional piece in the prescribers' toolbox to guide prescribing decisions.Other intrinsic and extrinsic factors should be considered for more accurate and personalized prescribing practice.This paper aims to guide clinicians with preparatory steps and "clinical pearls" necessary to successfully integrate pharmacogenetics into routine practice.
No takes yet. Share an insight, caveat, or question.
Obeng et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: